Variant report
Variant | nsv523903 |
---|---|
Chromosome Location | chr13:55552706-55554303 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OLFM4-6 | chr13:55553445-55553526 | XLOC_010401 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs54939 | chr13:55552706-55552707 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs115105046 | chr13:55552714-55552715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147873973 | chr13:55552741-55552742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs5803718 | chr13:55552786-55552787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34134442 | chr13:55552787-55552788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs200458881 | chr13:55552789-55552790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs373823278 | chr13:55552790-55552791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs386379244 | chr13:55552797-55552798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs59175572 | chr13:55552800-55552801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529754356 | chr13:55552803-55552804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549790787 | chr13:55552837-55552838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12583072 | chr13:55552879-55552880 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs548828217 | chr13:55552885-55552886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113102451 | chr13:55552886-55552887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537004989 | chr13:55552921-55552922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371450003 | chr13:55552929-55552930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148528000 | chr13:55552960-55552961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs377242179 | chr13:55552965-55552966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570251285 | chr13:55552995-55552996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182435988 | chr13:55553048-55553049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540827474 | chr13:55553049-55553050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553130663 | chr13:55553084-55553085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs61250747 | chr13:55553112-55553113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs263830 | chr13:55553113-55553114 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs141580110 | chr13:55553215-55553216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555609926 | chr13:55553227-55553228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574746831 | chr13:55553259-55553260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147056160 | chr13:55553270-55553271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs9536931 | chr13:55553277-55553278 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs532700657 | chr13:55553290-55553291 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547535266 | chr13:55553334-55553335 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563402917 | chr13:55553346-55553347 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530492069 | chr13:55553353-55553354 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369901093 | chr13:55553356-55553357 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113458194 | chr13:55553404-55553405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114260415 | chr13:55553470-55553471 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs560003644 | chr13:55553481-55553482 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs528669083 | chr13:55553482-55553483 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs548603883 | chr13:55553521-55553522 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs185916790 | chr13:55553542-55553543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536687269 | chr13:55553546-55553547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556559486 | chr13:55553572-55553573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190629935 | chr13:55553598-55553599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372190159 | chr13:55553657-55553658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550595397 | chr13:55553662-55553663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570090165 | chr13:55553678-55553679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73204646 | chr13:55553715-55553716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149288014 | chr13:55553796-55553797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566353602 | chr13:55553797-55553798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576697187 | chr13:55553835-55553836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 18852474 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:55550200-55553400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr13:55553200-55554200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr13:55553400-55554400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr13:55553800-55554200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr13:55554000-55555800 | Enhancers | Dnd41 | blood |